	Natural history of untreated prostate cancer: a comprehensive review of long-term progression patterns and survival outcomes. Prostate Cancer Prostatic Dis Tewari AK, Mehrazin R, Wiklund P, DeMeo M, Kaplan SA, Te AE. PMID: 41792475 [PubMed - as supplied by publisher]
	Predictors of Residual Tumour in Non-Muscle-Invasive Bladder Cancer Following Repeat Transurethral Resection: A Meta-Analysis. J Coll Physicians Surg Pak Li J, He Y, Wu S. PMID: 41792072 [PubMed - in process]
	Accuracy of diagnostic codes to identify metastatic prostate cancer in medicare claims database. Cancer Epidemiol Zhou B, Raval AD, Zhang Y, Sambamoorthi N, Sambamoorthi U. PMID: 41791349 [PubMed - as supplied by publisher]
	Virtual Versus In-Person Visits in Prostate Cancer: Communication and Patient-Reported Outcomes From a Prospective Observational Study in Jordan. JCO Glob Oncol Abaza H, Alzibdeh A, Khanfar A, Al-Ibraheem A, Khader J, Al-Sayed M, Almousa A, Mohamad I, Abuhijla F, Abdel-Razeq H, Al-Omari A, Abu-Hijlih R. PMID: 41791012 [PubMed - in process]
	Incidental renal pelvis and ureteral verrucous carcinoma: A case report and literature review. Medicine (Baltimore) Yang Z, Liu Y, Zhang X, Song L, Jiang J, Pan J, Li J, Li J. PMID: 41790656 [PubMed - indexed for MEDLINE]
	Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival. JAMA Netw Open Büttner T, Klümper N, Ellinger J, Ritter M, Krausewitz P. PMID: 41790469 [PubMed - in process]
	Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology. Discov Oncol Guo A, Lu Y, Wang J, Jia Z, Yang J, Ning X. PMID: 41790354 [PubMed - as supplied by publisher]
	Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer. Radiat Environ Biophys Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran . PMID: 41790195 [PubMed - as supplied by publisher]
	Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population. Mol Carcinog Chaves JR, Burbano RMR, Cohen-Paes AN, Alcântara DDFÁ, de Souza APB, Gomes MJN, Ramos SAA, Khayat AS. PMID: 41789775 [PubMed - as supplied by publisher]
	Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions. Curr Opin Oncol Shi X, Rifai S, Meher Z, Hussain A. PMID: 41789650 [PubMed - as supplied by publisher]
	SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer. Front Cell Infect Microbiol Qi T, Yang W, Liu R, Deng D, Liu X. PMID: 41789425 [PubMed - in process]
	Study on the prediction of postoperative metastasis in renal cancer using perirenal fat CT radiomics combined with clinical features. Front Oncol Zhou J, Zhou T, Yang Y, Zhang C, Ma Y, Xu J. PMID: 41788995 [PubMed]
	Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study. Front Oncol Pantano F, Malgeri A, De Giorgi U, Maruzzo M, Fornarini G, Zucali P, Fratino L, Milella M, Pedrazzoli P, Procopio G, Stellato M, Naglieri E, Soto Parra H, Napoli MD, Mollica V, Tudini M, Pipitone S, Santoni M, Ricotta R, Banna GL, Catalano F, Cavo A, Vignani F, Masini C, Casadei C, Galli L, Nolè F, Sorarù M, Prati V, Panni S, Roviello G, Prati G, Morelli F, Messina C, Atzori F, Rescigno P, Santini D, Buti S, Rebuzzi SE. PMID: 41788982 [PubMed]
	A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation results. Cancer Res Commun Talmor B, Marastoni S, Lau B, Yam AO, Yeung N, Lin HM, Li ZJ, Woo H, Pranavan G, Stricker PD, Horvath LG, Koritzinsky M, Wouters BG, Crumbaker M, Joshua AM. PMID: 41788020 [PubMed - as supplied by publisher]
	Diagnostic accuracy of (68)Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer. Sci Prog Qin Z, Pan G, Huang W, Xu L, Jia R. PMID: 41787866 [PubMed - in process]
	Multifocal cohort analysis unveils cell types associated with regional lymph node seeding in prostate cancer. Genome Med de Schaetzen van Brienen L, Jung T, Larmuseau M, Van der Eecken K, Van Hecke M, Haerinck J, De Coninck J, Vanwelkenhuyzen J, Lumen N, De Laere B, De Witte N, Miclotte G, Verbeke S, Berx G, Van Dorpe J, Ost P, Marchal K. PMID: 41787470 [PubMed - as supplied by publisher]
	Exercise and Phellodendron amurense extract differentially impinge on oxidative stress response pathways in a mouse model of prostate cancer. Sci Rep Patel DI, Rivas P, Chen Y, Lai Z, Ikeno Y, Kumar AP, Ghosh R. PMID: 41787055 [PubMed - as supplied by publisher]
	Glycoprotein biomarkers for bladder cancer detection. Clin Chim Acta Khan A, Alanazi FJ, Ahmed S, Alzahrani AR, Rehman ZU, Ali YH, Saeed IK, Siddique MI. PMID: 41786262 [PubMed - as supplied by publisher]
	Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial. Ann Oncol Choueiri TK, Albigès L, McDermott DF, Hammers HJ, Escudier B, Burotto M, Plimack ER, Porta C, George S, Powles T, Donskov F, Atkins MB, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Castellano D, Grünwald V, Tomita Y, Rini BI, Jiang R, van Kooten Losio M, Lee CW, Tannir NM, Motzer RJ. PMID: 41786248 [PubMed - as supplied by publisher]
	Real-World Data on Neoadjuvant Chemotherapy for Localized Muscle-Invasive Bladder Cancer (2015-2024): A Single-Center Retrospective Study. Fr J Urol Tanguy M, Armelle P, Sheik E, Nicolas I, Caroline C, Simon B, Mikael AA, Maxime V, Stessy K. PMID: 41786089 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176497

Page 1 of 8825



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy